CERO THERAPEUTICS HOLDINGS, INC.
Immunotherapy company developing engineered T cell therapeutics for cancer treatment.
CERO | US
Overview
Corporate Details
- ISIN(s):
- US71902K2042 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 201 HASKINS WAY, 94080 SOUTH SAN FRANCISCO
- Sector:
- Manufacturing
Description
CERo Therapeutics Holdings, Inc. is an immunotherapy company focused on advancing the development of engineered T cell therapeutics for the treatment of cancer. The company is pioneering a new generation of autologous T-cell-based therapies that uniquely combine attributes of macrophages and dendritic cells from the innate immune system. This approach is designed to incorporate multiple forms of tumor clearance into single T cells, creating a new class of innovative medicines for oncology. The company's mission is to discover, translate, and deliver these pioneering curative cell therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CERO THERAPEUTICS HOLDINGS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CERO THERAPEUTICS HOLDINGS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CERO THERAPEUTICS HOLDINGS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
